A Myeloid Lineage Signifying Anti-tumor Necrosis Factor Resistance in Crohn’s DiseaseSummary

Background & Aims: Although anti-tumor necrosis factor (TNF) therapy has improved Crohn’s disease (CD) management, the development of a refractory phenotype having resistance to the drug is not uncommon. The mechanisms behind this anti-TNF nonresponse are unknown but are likely multifactorial. H...

Бүрэн тодорхойлолт

Номзүйн дэлгэрэнгүй

Үндсэн зохиолчид:	Sachith Munasinghe, Duke Geem, Kodhai Duraiarasan, Sushma C. Maddipatla, Shanta Murthy, Yeonjoo Hwang, Ranjit S. Pelia, Murugadas Anbazhagan, Garima Sharma, Vikram Koti, Irina Geiculescu, Barbara J. Niklinsa-Schirtz, Cary Sauer, Raghavan Chinnadurai, Vasantha L. Kolachala, Jason D. Matthews, Subra Kugathasan
Формат:	Artigo
Хэл сонгох:	Inglês
Хэвлэсэн:	Elsevier 2026-01-01
Цуврал:	Cellular and Molecular Gastroenterology and Hepatology
Нөхцлүүд:	Anti-TNF CD47 Inflammatory Bowel Disease Refractory Crohn’s Disease SIRPα
Онлайн хандалт:	http://www.sciencedirect.com/science/article/pii/S2352345X25001778
Шошгууд:	Шошго нэмэх Шошго байхгүй, Энэхүү баримтыг шошголох эхний хүн болох!